{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Inflammation", "Inflammatory diseases", "Mammalian target of rapamycin", "Oxidative stress", "Statins"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36574095", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "27"}], "Language": ["eng"], "ELocationID": ["10.1007/s10787-022-01077-w"], "Journal": {"ISSN": "1568-5608", "JournalIssue": {"Volume": "31", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Feb"}}, "Title": "Inflammopharmacology", "ISOAbbreviation": "Inflammopharmacology"}, "ArticleTitle": "Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases.", "Pagination": {"StartPage": "57", "EndPage": "75", "MedlinePgn": "57-75"}, "Abstract": {"AbstractText": ["Inflammation plays a critical role in several diseases such as cancer, gastric, heart and nervous system diseases. Data suggest that the activation of mammalian target of rapamycin (mTOR) pathway in epithelial cells leads to inflammation. Statins, the inhibitors of the 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA), seem to be able to inhibit the mTOR. Statins are considered to have favorable effects on inflammatory diseases by reducing the complications caused by inflammation and by regulating the inflammatory process and cytokines secretion. This critical review collected data on this topic from clinical, in vivo and in vitro studies published between 1998 and June 2022 in English from databases including PubMed, Google Scholar, Scopus, and Cochrane libraries."], "CopyrightInformation": "\u00a9 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}], "LastName": "Lashgari", "ForeName": "Naser-Aldin", "Initials": "NA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}], "LastName": "Roudsari", "ForeName": "Nazanin Momeni", "Initials": "NM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran."}], "LastName": "Zadeh", "ForeName": "Seyed Saeed Tamehri", "Initials": "SST"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group (TDG), The Institute of Pharmaceutical Sciences (TIPS), and Faculty of Pharmacy, Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran."}, {"Identifier": [], "Affiliation": "Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran."}], "LastName": "Abbasifard", "ForeName": "Mitra", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, School of Medicine, University Hospital Center Zagreb, University of Zagreb, Zagreb, Croatia."}], "LastName": "Reiner", "ForeName": "\u017deljko", "Initials": "\u017d"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. amirhosein172@hotmail.com."}, {"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Tehran, Iran. amirhosein172@hotmail.com."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group (TDG), The Institute of Pharmaceutical Sciences (TIPS), and Faculty of Pharmacy, Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences, Tehran, Iran. amirhosein172@hotmail.com."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran. amirhosein172@hotmail.com."}], "LastName": "Abdolghaffari", "ForeName": "Amir Hossein", "Initials": "AH"}, {"Identifier": ["0000-0002-8656-1444"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. amir_saheb2000@yahoo.com."}, {"Identifier": [], "Affiliation": "Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. amir_saheb2000@yahoo.com."}, {"Identifier": [], "Affiliation": "School of Medicine, The University of Western Australia, Perth, Australia. amir_saheb2000@yahoo.com."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. amir_saheb2000@yahoo.com."}], "LastName": "Sahebkar", "ForeName": "Amirhossein", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Inflammopharmacology", "NlmUniqueID": "9112626", "ISSNLinking": "0925-4692"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "TOR Serine-Threonine Kinases"}, {"RegistryNumber": "W36ZG6FT64", "NameOfSubstance": "Sirolimus"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neurodegenerative Diseases"}, {"QualifierName": [], "DescriptorName": "TOR Serine-Threonine Kinases"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Sirolimus"}], "CoiStatement": "The authors declare that there is no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Adhyaru BB, Jacobson TA. Safety and efficacy of statin therapy. Nat Rev Cardiol. 2018;15(12):757\u2013769. doi: 10.1038/s41569-018-0098-5.", "ArticleIdList": ["10.1038/s41569-018-0098-5", "30375494"]}, {"Citation": "Afify SM, Oo AKK, Hassan G, Seno A, Seno M. How can we turn the PI3K/AKT/mTOR pathway down? Insights into inhibition and treatment of cancer. Expert Rev Anticancer Ther. 2021 doi: 10.1080/14737140.2021.1918001.", "ArticleIdList": ["10.1080/14737140.2021.1918001", "33857392"]}, {"Citation": "Al-Asmari AK, Ullah Z, Al Masoudi AS, Ahmad I. Simultaneous administration of fluoxetine and simvastatin ameliorates lipid profile, improves brain level of neurotransmitters, and increases bioavailability of simvastatin. J Exp Pharmacol. 2017;9:47. doi: 10.2147/JEP.S128696.", "ArticleIdList": ["10.2147/JEP.S128696", "PMC5395284", "28442937"]}, {"Citation": "Appelberg S, Gupta S, Svensson Akusj\u00e4rvi S, Ambikan AT, Mikaeloff F, Saccon E, et al. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerg Microbes Infect. 2020;9(1):1748\u20131760. doi: 10.1080/22221751.2020.1799723.", "ArticleIdList": ["10.1080/22221751.2020.1799723", "PMC7473213", "32691695"]}, {"Citation": "Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u2013691. doi: 10.1136/gutjnl-2015-310912.", "ArticleIdList": ["10.1136/gutjnl-2015-310912", "26818619"]}, {"Citation": "Asai J, Takenaka H, Hirakawa S, Sakabe J-I, Hagura A, Kishimoto S, et al. Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis. Am J Pathol. 2012;181(6):2217\u20132224. doi: 10.1016/j.ajpath.2012.08.023.", "ArticleIdList": ["10.1016/j.ajpath.2012.08.023", "23138019"]}, {"Citation": "Atochina-Vasserman EN, Goncharov DA, Volgina AV, Milavec M, James ML, Krymskaya VP. Statins in lymphangioleiomyomatosis. Simvastatin and atorvastatin induce differential effects on tuberous sclerosis complex 2\u2013Null cell growth and signaling. Am J Respir Cell Mol Biol. 2013;49(5):704\u2013709. doi: 10.1165/rcmb.2013-0203RC.", "ArticleIdList": ["10.1165/rcmb.2013-0203RC", "PMC3931105", "23947572"]}, {"Citation": "Backes JM, Hilleman DE. New and emerging lipid-lowering therapy. Future Cardiol. 2021;17(8):1407\u20131420. doi: 10.2217/fca-2020-0217.", "ArticleIdList": ["10.2217/fca-2020-0217", "33646009"]}, {"Citation": "Bahrami A, Bo S, Jamialahmadi T, Sahebkar A. Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: molecular mechanisms. Ageing Res Rev. 2020 doi: 10.1016/j.arr.2020.101024.", "ArticleIdList": ["10.1016/j.arr.2020.101024", "32006687"]}, {"Citation": "Bahrami A, Parsamanesh N, Atkin SL, Banach M, Sahebkar A (2018) Effect of statins on toll-like receptors: a new insight to pleiotropic effects. Pharmacol Res 135:230\u2013238. 10.1016/j.phrs.2018.08.014", "ArticleIdList": ["30120976"]}, {"Citation": "Banach M, Serban C, Ursoniu S, Rysz J, Muntner P, Toth PP, Jones SR, Rizzo M, Glasser SP, Watts GF, Blumenthal RS, Lip GY, Mikhailidis DP, Sahebkar A, Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group (2015). Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trials. Pharmacol Res 99:329\u2013336. 10.1016/j.phrs.2015.07.008", "ArticleIdList": ["26192349"]}, {"Citation": "Bashir MN. Epidemiology of prostate cancer. Asian Pac J Cancer Prev. 2015;16(13):5137\u20135141. doi: 10.7314/APJCP.2015.16.13.5137.", "ArticleIdList": ["10.7314/APJCP.2015.16.13.5137", "26225642"]}, {"Citation": "Bernier J, Bentzen SM, Vermorken JB. Molecular therapy in head and neck oncology. Nat Rev Clin Oncol. 2009;6(5):266\u2013277. doi: 10.1038/nrclinonc.2009.40.", "ArticleIdList": ["10.1038/nrclinonc.2009.40", "19390553"]}, {"Citation": "Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med. 2008;358(2):140\u2013151. doi: 10.1056/NEJMoa063564.", "ArticleIdList": ["10.1056/NEJMoa063564", "PMC3398441", "18184959"]}, {"Citation": "Bitto A, Minutoli L, Altavilla D, Polito F, Fiumara T, Marini H, et al. Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes. Pharmacol Res. 2008;57(2):159\u2013169. doi: 10.1016/j.phrs.2008.01.005.", "ArticleIdList": ["10.1016/j.phrs.2008.01.005", "18316203"]}, {"Citation": "Blakytny R, Jude E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med. 2006;23(6):594\u2013608. doi: 10.1111/j.1464-5491.2006.01773.x.", "ArticleIdList": ["10.1111/j.1464-5491.2006.01773.x", "16759300"]}, {"Citation": "Bland AR, Payne FM, Ashton JC, Jamialahmadi T, Sahebkar A (2022) The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury. Pharmacol Res 175:105986. 10.1016/j.phrs.2021.105986", "ArticleIdList": ["34800627"]}, {"Citation": "Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001;3(11):1014\u20131019. doi: 10.1038/ncb1101-1014.", "ArticleIdList": ["10.1038/ncb1101-1014", "11715023"]}, {"Citation": "Bonifacio A, Sanvee GM, Bouitbir J, Kr\u00e4henb\u00fchl S. The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity. Biochim Biophys Acta (BBA) 2015;1853(8):1841\u20139. doi: 10.1016/j.bbamcr.2015.04.010.", "ArticleIdList": ["10.1016/j.bbamcr.2015.04.010", "25913013"]}, {"Citation": "Bonovas S, Filioussi K, Flordellis CS, Sitaras NM (2007) Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol 25(23):3462\u20133468. 10.1200/JCO.2007.10.8936", "ArticleIdList": ["17687150"]}, {"Citation": "Borgquist S, Bjarnadottir O, Kimbung S, Ahern T. Statins: a role in breast cancer therapy? J Intern Med. 2018;284(4):346\u2013357. doi: 10.1111/joim.12806.", "ArticleIdList": ["10.1111/joim.12806", "PMC6175478", "29923256"]}, {"Citation": "Bouitbir J, Sanvee GM, Panajatovic MV, Singh F, Kr\u00e4henb\u00fchl S. Mechanisms of statin-associated skeletal muscle-associated symptoms. Pharmacol Res. 2020;154:104201. doi: 10.1016/j.phrs.2019.03.010.", "ArticleIdList": ["10.1016/j.phrs.2019.03.010", "30877064"]}, {"Citation": "Calautti E, Li J, Saoncella S, Brissette JL, Goetinck PF. Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem. 2005;280(38):32856\u201332865. doi: 10.1074/jbc.M506119200.", "ArticleIdList": ["10.1074/jbc.M506119200", "16036919"]}, {"Citation": "Castilho RM, Squarize CH, Gutkind JS. Exploiting PI 3 K/m TOR signaling to accelerate epithelial wound healing. Oral Dis. 2013;19(6):551\u2013558. doi: 10.1111/odi.12070.", "ArticleIdList": ["10.1111/odi.12070", "PMC4764999", "23379329"]}, {"Citation": "Chidambaram V, Castillo JR, Kumar A, Wei J, Wang S, Majella MG, et al. The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis. Sci Rep. 2021 doi: 10.1038/s41598-021-94590-x.", "ArticleIdList": ["10.1038/s41598-021-94590-x", "PMC8316554", "34315941"]}, {"Citation": "Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;311(16):1670\u20131683. doi: 10.1001/jama.2014.3654.", "ArticleIdList": ["10.1001/jama.2014.3654", "24756517"]}, {"Citation": "Cowen P. Backing into the future: pharmacological approaches to the management of resistant depression. Psychol Med. 2017;47(15):2569\u20132577. doi: 10.1017/S003329171700068X.", "ArticleIdList": ["10.1017/S003329171700068X", "PMC5635969", "28838328"]}, {"Citation": "Crossland H, Constantin-Teodosiu D, Gardiner SM, Constantin D, Greenhaff PL. A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle. J Physiol. 2008;586(22):5589\u20135600. doi: 10.1113/jphysiol.2008.160150.", "ArticleIdList": ["10.1113/jphysiol.2008.160150", "PMC2655379", "18818241"]}, {"Citation": "Cui X, Long C, Tian J, Zhu J. Protective effects of fluvastatin on reproductive function in obese male rats induced by high-fat diet through enhanced signaling of mTOR. Cell Physiol Biochem. 2017;41(2):598\u2013608. doi: 10.1159/000457881.", "ArticleIdList": ["10.1159/000457881", "28214901"]}, {"Citation": "Dabora SL, Franz DN, Ashwal S, Sagalowsky A, DiMario FJ, Jr, Miles D, et al. Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF-D levels decrease. PLoS One. 2011;6(9):e23379. doi: 10.1371/journal.pone.0023379.", "ArticleIdList": ["10.1371/journal.pone.0023379", "PMC3167813", "21915260"]}, {"Citation": "Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP-Y, Baldwin AS. Akt-dependent regulation of NF-\u03baB is controlled by mTOR and raptor in association with IKK. Genes Dev. 2008;22(11):1490\u20131500. doi: 10.1101/gad.1662308.", "ArticleIdList": ["10.1101/gad.1662308", "PMC2418585", "18519641"]}, {"Citation": "Davies DM, de Vries PJ, Johnson SR, McCartney DL, Cox JA, Serra AL, et al. Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res. 2011;17(12):4071\u20134081. doi: 10.1158/1078-0432.CCR-11-0445.", "ArticleIdList": ["10.1158/1078-0432.CCR-11-0445", "21525172"]}, {"Citation": "Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26(3):319\u2013330. doi: 10.1016/j.ccr.2014.07.014.", "ArticleIdList": ["10.1016/j.ccr.2014.07.014", "PMC4160352", "25155756"]}, {"Citation": "Dazert E, Hall MN. mTOR signaling in disease. Curr Opin Cell Biol. 2011;23(6):744\u2013755. doi: 10.1016/j.ceb.2011.09.003.", "ArticleIdList": ["10.1016/j.ceb.2011.09.003", "21963299"]}, {"Citation": "Deeter L, Seaton M, Carrougher GJ, McMullen K, Mandell SP, Amtmann D, et al. Hospital-acquired complications alter quality of life in adult burn survivors: report from a burn model system. Burns. 2019;45(1):42\u201347. doi: 10.1016/j.burns.2018.10.010.", "ArticleIdList": ["10.1016/j.burns.2018.10.010", "30477817"]}, {"Citation": "Dehnavi S, Kiani A, Sadeghi M, Biregani AF, Banach M, Atkin SL, et al. Targeting AMPK by statins: a potential therapeutic approach. Drugs. 2021;81(8):923\u2013933. doi: 10.1007/s40265-021-01510-4.", "ArticleIdList": ["10.1007/s40265-021-01510-4", "PMC8144155", "33939118"]}, {"Citation": "Dowling RJ, Topisirovic I, Alain T, Bidinosti M, Fonseca BD, Petroulakis E, et al. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science. 2010;328(5982):1172\u20131176. doi: 10.1126/science.1187532.", "ArticleIdList": ["10.1126/science.1187532", "PMC2893390", "20508131"]}, {"Citation": "ElBatsh MM. Antidepressant-like effect of simvastatin in diabetic rats. Can J Physiol Pharmacol. 2015;93(8):649\u2013656. doi: 10.1139/cjpp-2014-0560.", "ArticleIdList": ["10.1139/cjpp-2014-0560", "26120891"]}, {"Citation": "Emanueli C, Monopoli A, Kraenkel N, Meloni M, Gadau S, Campesi I, et al. Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb ischaemia in type-1 diabetic mice. Br J Pharmacol. 2007;150(7):873\u2013882. doi: 10.1038/sj.bjp.0707142.", "ArticleIdList": ["10.1038/sj.bjp.0707142", "PMC2013882", "17351667"]}, {"Citation": "Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7(8):606\u2013619. doi: 10.1038/nrg1879.", "ArticleIdList": ["10.1038/nrg1879", "16847462"]}, {"Citation": "Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 2007;356(2):125\u2013134. doi: 10.1056/NEJMoa060655.", "ArticleIdList": ["10.1056/NEJMoa060655", "17215530"]}, {"Citation": "Fadini GP, Albiero M, Menegazzo L, Boscaro E, Pagnin E, Iori E, et al. The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healing. Diabetes. 2010;59(9):2306\u20132314. doi: 10.2337/db09-1727.", "ArticleIdList": ["10.2337/db09-1727", "PMC2927954", "20566667"]}, {"Citation": "Fang Z, Tang Y, Fang J, Zhou Z, Xing Z, Guo Z, et al. Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway. PLoS One. 2013;8(5):e62823. doi: 10.1371/journal.pone.0062823.", "ArticleIdList": ["10.1371/journal.pone.0062823", "PMC3656850", "23690956"]}, {"Citation": "Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci. 2005;102(23):8204\u20138209. doi: 10.1073/pnas.0502857102.", "ArticleIdList": ["10.1073/pnas.0502857102", "PMC1142118", "15928081"]}, {"Citation": "Fruman DA, Rommel C. PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov. 2014;13(2):140\u2013156. doi: 10.1038/nrd4204.", "ArticleIdList": ["10.1038/nrd4204", "PMC3994981", "24481312"]}, {"Citation": "Furukawa TA, Cipriani A, Atkinson LZ, Leucht S, Ogawa Y, Takeshima N, et al. Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies. Lancet Psychiatry. 2016;3(11):1059\u20131066. doi: 10.1016/S2215-0366(16)30307-8.", "ArticleIdList": ["10.1016/S2215-0366(16)30307-8", "27726982"]}, {"Citation": "Gagliano T, Bellio M, Gentilin E, Mole D, Tagliati F, Schiavon M, et al. mTOR, p70S6K, AKT, and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids. Endocr Relat Cancer. 2013;20(4):463\u2013475. doi: 10.1530/ERC-13-0042.", "ArticleIdList": ["10.1530/ERC-13-0042", "23653462"]}, {"Citation": "Garcia G, Jr, Sharma A, Ramaiah A, Sen C, Kohn DB, Gomperts BN, et al. Antiviral drug screen of kinase inhibitors identifies cellular signaling pathways critical for SARS-CoV-2 replication. SSRN J. 2020 doi: 10.2139/ssrn.3682004.", "ArticleIdList": ["10.2139/ssrn.3682004"]}, {"Citation": "Gazzerro P, Proto MC, Gangemi G, Malfitano AM, Ciaglia E, Pisanti S, et al. Pharmacological actions of statins: a critical appraisal in the management of cancer. Pharmacol Rev. 2012;64(1):102\u2013146. doi: 10.1124/pr.111.004994.", "ArticleIdList": ["10.1124/pr.111.004994", "22106090"]}, {"Citation": "Gingras A-C, Kennedy SG, O\u2019Leary MA, Sonenberg N, Hay N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt (PKB) signaling pathway. Genes Dev. 1998;12(4):502\u2013513. doi: 10.1101/gad.12.4.502.", "ArticleIdList": ["10.1101/gad.12.4.502", "PMC316523", "9472019"]}, {"Citation": "Giudice FS, Squarize CH. The determinants of head and neck cancer: unmasking the PI3K pathway mutations. J Carcinog Mutagen. 2013 doi: 10.4172/2157-2518.S5-003.", "ArticleIdList": ["10.4172/2157-2518.S5-003", "PMC4130654", "25126449"]}, {"Citation": "Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918\u2013934. doi: 10.1016/j.cell.2010.02.016.", "ArticleIdList": ["10.1016/j.cell.2010.02.016", "PMC2873093", "20303880"]}, {"Citation": "Goncharova EA, Goncharov DA, Eszterhas A, Hunter DS, Glassberg MK, Yeung RS, et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM) J Biol Chem. 2002;277(34):30958\u201330967. doi: 10.1074/jbc.M202678200.", "ArticleIdList": ["10.1074/jbc.M202678200", "12045200"]}, {"Citation": "Gosain A, DiPietro LA. Aging and wound healing. World J Surg. 2004;28(3):321\u2013326. doi: 10.1007/s00268-003-7397-6.", "ArticleIdList": ["10.1007/s00268-003-7397-6", "14961191"]}, {"Citation": "Grabiner BC, Nardi V, Birsoy K, Possemato R, Shen K, Sinha S, et al. A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov. 2014;4(5):554\u2013563. doi: 10.1158/2159-8290.CD-13-0929.", "ArticleIdList": ["10.1158/2159-8290.CD-13-0929", "PMC4012430", "24631838"]}, {"Citation": "Han F, Xiao QQ, Peng S, Che XY, Jiang LS, Shao Q, et al. Atorvastatin ameliorates LPS-induced inflammatory response by autophagy via AKT/mTOR signaling pathway. J Cell Biochem. 2018;119(2):1604\u20131615. doi: 10.1002/jcb.26320.", "ArticleIdList": ["10.1002/jcb.26320", "28771872"]}, {"Citation": "Hanai J-I, Cao P, Tanksale P, Imamura S, Koshimizu E, Zhao J, et al. The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity. J Clin Invest. 2007;117(12):3940\u20133951.", "ArticleIdList": ["PMC2066198", "17992259"]}, {"Citation": "Hardt M, Chantaravisoot N, Tamanoi F. Activating mutations of TOR (target of rapamycin) Genes Cells. 2011;16(2):141\u2013151. doi: 10.1111/j.1365-2443.2010.01482.x.", "ArticleIdList": ["10.1111/j.1365-2443.2010.01482.x", "PMC3116645", "21210909"]}, {"Citation": "Hassanabad AF. Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms. Transl Lung Cancer Res. 2019;8(5):692. doi: 10.21037/tlcr.2019.09.08.", "ArticleIdList": ["10.21037/tlcr.2019.09.08", "PMC6835101", "31737505"]}, {"Citation": "Hern\u00e1ndez G, Lal H, Fidalgo M, Guerrero A, Zalvide J, Force T, et al. A novel cardioprotective p38-MAPK/mTOR pathway. Exp Cell Res. 2011;317(20):2938\u20132949. doi: 10.1016/j.yexcr.2011.09.011.", "ArticleIdList": ["10.1016/j.yexcr.2011.09.011", "PMC3215777", "22001647"]}, {"Citation": "Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, et al. Nutrient-dependent mTORC1 association with the ULK1\u2013Atg13\u2013FIP200 complex required for autophagy. Mol Biol Cell. 2009;20(7):1981\u20131991. doi: 10.1091/mbc.e08-12-1248.", "ArticleIdList": ["10.1091/mbc.e08-12-1248", "PMC2663915", "19211835"]}, {"Citation": "Hsieh AC, Costa M, Zollo O, Davis C, Feldman ME, Testa JR, et al. Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Cancer Cell. 2010;17(3):249\u2013261. doi: 10.1016/j.ccr.2010.01.021.", "ArticleIdList": ["10.1016/j.ccr.2010.01.021", "PMC2901095", "20227039"]}, {"Citation": "Hu T, Shen H, Huang H, Yang Z, Zhou Y, Zhao G. Cholesterol-lowering drug pitavastatin targets lung cancer and angiogenesis via suppressing prenylation-dependent Ras/Raf/MEK and PI3K/Akt/mTOR signaling. Anticancer Drugs. 2020;31(4):377\u2013384. doi: 10.1097/CAD.0000000000000885.", "ArticleIdList": ["10.1097/CAD.0000000000000885", "32011362"]}, {"Citation": "Huang H, Cui W, Qiu W, Zhu M, Zhao R, Zeng D, et al. Impaired wound healing results from the dysfunction of the Akt/mTOR pathway in diabetic rats. J Dermatol Sci. 2015;79(3):241\u2013251. doi: 10.1016/j.jdermsci.2015.06.002.", "ArticleIdList": ["10.1016/j.jdermsci.2015.06.002", "26091964"]}, {"Citation": "Iacobuzio-Donahue CA, Herman JM. Autophagy, p53, and pancreatic cancer. N Engl J Med. 2014;370(14):1352\u20131353. doi: 10.1056/NEJMcibr1400189.", "ArticleIdList": ["10.1056/NEJMcibr1400189", "24693896"]}, {"Citation": "Islam MM, Yang H-C, Nguyen P-A, Poly TN, Huang C-W, Kekade S, et al. Exploring association between statin use and breast cancer risk: an updated meta-analysis. Arch Gynecol Obstet. 2017;296(6):1043\u20131053. doi: 10.1007/s00404-017-4533-3.", "ArticleIdList": ["10.1007/s00404-017-4533-3", "28940025"]}, {"Citation": "Iwasaki Y, Sugimoto H, Ikeda K, Takamiya K, Shiojima T, Kinoshita M. Muscle morphometry in amyotrophic lateral sclerosis. Int J Neurosci. 1991;58(3\u20134):165\u2013170. doi: 10.3109/00207459108985432.", "ArticleIdList": ["10.3109/00207459108985432", "1365039"]}, {"Citation": "Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4(12):977\u2013987. doi: 10.1038/nrd1901.", "ArticleIdList": ["10.1038/nrd1901", "16341063"]}, {"Citation": "James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u20131858. doi: 10.1016/S0140-6736(18)32279-7.", "ArticleIdList": ["10.1016/S0140-6736(18)32279-7", "PMC6227754", "30496104"]}, {"Citation": "Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet. 2003;361(9368):1545\u20131551. doi: 10.1016/S0140-6736(03)13169-8.", "ArticleIdList": ["10.1016/S0140-6736(03)13169-8", "12737879"]}, {"Citation": "Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA. 2011;61(2):69\u201390.", "ArticleIdList": ["21296855"]}, {"Citation": "Jensen L, J\u00f8rgensen L, Bech R, Frandsen U, Schr\u00f8der H. Skeletal muscle remodelling as a function of disease progression in amyotrophic lateral sclerosis. BioMed Res Int. 2016 doi: 10.1155/2016/5930621.", "ArticleIdList": ["10.1155/2016/5930621", "PMC4852332", "27195289"]}, {"Citation": "Jim\u00e9nez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, S\u00e1ez-Mart\u00ednez P, G\u00f3mez-G\u00f3mez E, Le\u00f3n-Gonz\u00e1lez AJ, et al. Clinical, cellular, and molecular evidence of the additive antitumor effects of biguanides and statins in prostate cancer. J Clin Endocrinol Metab. 2021;106(2):e696\u2013e710. doi: 10.1210/clinem/dgaa877.", "ArticleIdList": ["10.1210/clinem/dgaa877", "33247590"]}, {"Citation": "Jin Y, Sui H-J, Dong Y, Ding Q, Qu W-H, Yu S-X, et al. Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3\u03b2 signaling pathways. Acta Pharmacol Sin. 2012;33(7):861\u2013872. doi: 10.1038/aps.2012.59.", "ArticleIdList": ["10.1038/aps.2012.59", "PMC4011150", "22705730"]}, {"Citation": "Jones HM, Fang Z, Sun W, Clark LH, Stine JE, Tran A-Q, et al. Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro. Am J Cancer Res. 2017;7(12):2478.", "ArticleIdList": ["PMC5752688", "29312801"]}, {"Citation": "Jung CH, Jun CB, Ro S-H, Kim Y-M, Otto NM, Cao J, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell. 2009;20(7):1992\u20132003. doi: 10.1091/mbc.e08-12-1249.", "ArticleIdList": ["10.1091/mbc.e08-12-1249", "PMC2663920", "19225151"]}, {"Citation": "Kalia LV, Kalia SK, Lang AE. Disease-modifying strategies for Parkinson's disease. Mov Disord. 2015;30(11):1442\u20131450. doi: 10.1002/mds.26354.", "ArticleIdList": ["10.1002/mds.26354", "26208210"]}, {"Citation": "Kang SY, Lee S-B, Kim HJ, Kim H-T, Yang HO, Jang W. Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson\u2019s disease. Neurosci Lett. 2017;642:20\u201326. doi: 10.1016/j.neulet.2017.01.063.", "ArticleIdList": ["10.1016/j.neulet.2017.01.063", "28137648"]}, {"Citation": "Kaufmann P, T\u00f6r\u00f6k M, Zahno A, Waldhauser K, Brecht K, Kr\u00e4henb\u00fchl S. Toxicity of statins on rat skeletal muscle mitochondria. Cell Mol Life Sci CMLS. 2006;63(19):2415\u20132425. doi: 10.1007/s00018-006-6235-z.", "ArticleIdList": ["10.1007/s00018-006-6235-z", "17013560"]}, {"Citation": "Kaur K, Anant A, Asati V. Structural aspects of mTOR inhibitors in: progress to search potential compounds. Anti-cancer Agents Med Chem. 2021 doi: 10.2174/1871520621666210720121403.", "ArticleIdList": ["10.2174/1871520621666210720121403", "34288843"]}, {"Citation": "Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593\u2013602. doi: 10.1001/archpsyc.62.6.593.", "ArticleIdList": ["10.1001/archpsyc.62.6.593", "15939837"]}, {"Citation": "Khalifeh M, Penson PE, Banach M, Sahebkar A. Statins as anti-pyroptotic agents. Arch Med Sci. 2021;17(5):1414\u20131417. doi: 10.5114/aoms/141155.", "ArticleIdList": ["10.5114/aoms/141155", "PMC8425236", "34522271"]}, {"Citation": "Khan N. mTOR: a possible therapeutic target against SARS-CoV-2 infection. Arch Stem Cell Ther. 2021;2(1):5\u20137.", "ArticleIdList": ["PMC8225252", "34179893"]}, {"Citation": "Khan N, Chen X, Geiger JD. Possible therapeutic use of natural compounds against COVID-19. J Cell Signal. 2021;2(1):63.", "ArticleIdList": ["PMC7990267", "33768214"]}, {"Citation": "Khatami F, Saatchi M, Zadeh SST, Aghamir ZS, Shabestari AN, Reis LO, et al. A meta-analysis of accuracy and sensitivity of chest CT and RT-PCR in COVID-19 diagnosis. Sci Rep. 2020;10(1):1\u201312. doi: 10.1038/s41598-020-80061-2.", "ArticleIdList": ["10.1038/s41598-020-80061-2", "PMC7769992", "33372194"]}, {"Citation": "Kim K, Choi SH. Stroke revisited: dyslipidemia in stroke. Springer; 2021. Safety considerations of pharmacological treatment; pp. 203\u201319."}, {"Citation": "Kim YC, Guan K-L. mTOR: a pharmacologic target for autophagy regulation. J Clin Investig. 2015;125(1):25\u201332. doi: 10.1172/JCI73939.", "ArticleIdList": ["10.1172/JCI73939", "PMC4382265", "25654547"]}, {"Citation": "Kim MS, Kim JY. Ginger attenuates inflammation in a mouse model of dextran sulfate sodium-induced colitis. Food Sci Biotechnol. 2018;27(5):1493\u20131501. doi: 10.1007/s10068-018-0438-6.", "ArticleIdList": ["10.1007/s10068-018-0438-6", "PMC6170261", "30319860"]}, {"Citation": "Kim S-W, Kang H-J, Jhon M, Kim J-W, Lee J-Y, Walker AJ, et al. Statins and inflammation: new therapeutic opportunities in psychiatry. Front Psych. 2019;10:103. doi: 10.3389/fpsyt.2019.00103.", "ArticleIdList": ["10.3389/fpsyt.2019.00103", "PMC6413672", "30890971"]}, {"Citation": "Kitamura T, Asai N, Enomoto A, Maeda K, Kato T, Ishida M, et al. Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol. 2008;10(3):329\u2013337. doi: 10.1038/ncb1695.", "ArticleIdList": ["10.1038/ncb1695", "18264090"]}, {"Citation": "Kodach LL, Bleuming SA, Peppelenbosch MP, Hommes DW, van den Brink GR, Hardwick JC. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway. Gastroenterology. 2007;133(4):1272\u20131281. doi: 10.1053/j.gastro.2007.08.021.", "ArticleIdList": ["10.1053/j.gastro.2007.08.021", "17919499"]}, {"Citation": "Kotas ME, Medzhitov R. Homeostasis, inflammation, and disease susceptibility. Cell. 2015;160(5):816\u2013827. doi: 10.1016/j.cell.2015.02.010.", "ArticleIdList": ["10.1016/j.cell.2015.02.010", "PMC4369762", "25723161"]}, {"Citation": "Kouhpeikar H, Delbari Z, Sathyapalan T, Simental-Mend\u00eda LE, Jamialahmadi T, Sahebkar A (2020) The effect of statins through mast cells in the pathophysiology of atherosclerosis: a review. Curr Atheroscler Rep 22(5):19. 10.1007/s11883-020-00837-9", "ArticleIdList": ["32458165"]}, {"Citation": "Koushki K, Shahbaz S K, Mashayekhi K, Sadeghi M, Zayeri ZD, Taba MY, Banach M, Al Rasadi K, Johnston TP, Sahebkar A (2021) Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways. Clin Rev Allergy Immunol 60(2):175\u2013199. 10.1007/s12016-020-08791-9", "ArticleIdList": ["PMC7985098", "32378144"]}, {"Citation": "Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, El-Hashemite N, et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet. 2002;11(5):525\u201334. doi: 10.1093/hmg/11.5.525.", "ArticleIdList": ["10.1093/hmg/11.5.525", "11875047"]}, {"Citation": "Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274\u2013293. doi: 10.1016/j.cell.2012.03.017.", "ArticleIdList": ["10.1016/j.cell.2012.03.017", "PMC3331679", "22500797"]}, {"Citation": "Lashgari N-A, Roudsari NM, Momtaz S, Ghanaatian N, Kohansal P, Farzaei MH, et al. Targeting mammalian target of rapamycin: prospects for the treatment of inflammatory bowel diseases. Curr Med Chem. 2020 doi: 10.2174/0929867327666200504081503.", "ArticleIdList": ["10.2174/0929867327666200504081503", "32364064"]}, {"Citation": "Lashgari NA, Roudsari NM, Momtaz S, Ghanaatian N, Kohansal P, Farzaei MH, et al. Targeting mammalian target of rapamycin: prospects for the treatment of inflammatory bowel diseases. Curr Med Chem. 2020 doi: 10.2174/0929867327666200504081503.", "ArticleIdList": ["10.2174/0929867327666200504081503", "32364064"]}, {"Citation": "Lashgari N-A, Roudsari NM, Momtaz S, Sathyapalan T, Abdolghaffari AH, Sahebkar A. The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease. J Neuroimmunol. 2021;361:577758. doi: 10.1016/j.jneuroim.2021.577758.", "ArticleIdList": ["10.1016/j.jneuroim.2021.577758", "34739911"]}, {"Citation": "Lashgari N-A, Roudsari NM, Momtaz S, Abdolghaffari AH. Mammalian target of rapamycin; novel insight for management of inflammatory bowel diseases. World J Pharmacol. 2022;11(1):1\u20135. doi: 10.5497/wjp.v11.i1.1.", "ArticleIdList": ["10.5497/wjp.v11.i1.1"]}, {"Citation": "Lee D-F, Hung M-C. All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle. 2007;6(24):3011\u20133014. doi: 10.4161/cc.6.24.5085.", "ArticleIdList": ["10.4161/cc.6.24.5085", "18073529"]}, {"Citation": "Lepper C, Conway SJ, Fan C-M. Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements. Nature. 2009;460(7255):627\u2013631. doi: 10.1038/nature08209.", "ArticleIdList": ["10.1038/nature08209", "PMC2767162", "19554048"]}, {"Citation": "Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol. 2003;162(1):303\u2013312. doi: 10.1016/S0002-9440(10)63821-7.", "ArticleIdList": ["10.1016/S0002-9440(10)63821-7", "PMC1851127", "12507913"]}, {"Citation": "Li Y, Xu Y, Liu X, Yan X, Lin Y, Tan Q, et al. mTOR inhibitor INK128 promotes wound healing by regulating MDSCs. Stem Cell Res Ther. 2021;12(1):1\u201315. doi: 10.1186/s13287-021-02569-2.", "ArticleIdList": ["10.1186/s13287-021-02569-2", "PMC7944919", "33691762"]}, {"Citation": "Liao Y, Zhang P, Yuan B, Li L, Bao S. Pravastatin protects against avascular necrosis of femoral head via autophagy. Front Physiol. 2018;9:307. doi: 10.3389/fphys.2018.00307.", "ArticleIdList": ["10.3389/fphys.2018.00307", "PMC5900057", "29686621"]}, {"Citation": "Lim S-W, Shiue Y-L, Liao J-C, Wee H-Y, Wang C-C, Chio C-C, et al. Simvastatin therapy in the acute stage of traumatic brain injury attenuates brain trauma-induced depression-like behavior in rats by reducing neuroinflammation in the hippocampus. Neurocrit Care. 2017;26(1):122\u2013132. doi: 10.1007/s12028-016-0290-6.", "ArticleIdList": ["10.1007/s12028-016-0290-6", "27406816"]}, {"Citation": "Lindqvist L, Pelletier J. Inhibitors of translation initiation as cancer therapeutics. Future Med Chem. 2009;1(9):1709\u20131722. doi: 10.4155/fmc.09.122.", "ArticleIdList": ["10.4155/fmc.09.122", "21425987"]}, {"Citation": "Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol. 2010;7(5):277\u2013285. doi: 10.1038/nrurol.2010.47.", "ArticleIdList": ["10.1038/nrurol.2010.47", "PMC2929006", "20448661"]}, {"Citation": "Liu X-M, Zhao X-M, Deng C, Zeng Y-P, Hu C-H. Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway. Acta Pharmacol Sin. 2019;40(8):1049\u20131057. doi: 10.1038/s41401-019-0212-1.", "ArticleIdList": ["10.1038/s41401-019-0212-1", "PMC6786380", "30728467"]}, {"Citation": "Ludka FK, Zomkowski AD, Cunha MP, Dal-Cim T, Zeni ALB, Rodrigues ALS, et al. Acute atorvastatin treatment exerts antidepressant-like effect in mice via the L-arginine\u2013nitric oxide\u2013cyclic guanosine monophosphate pathway and increases BDNF levels. Eur Neuropsychopharmacol. 2013;23(5):400\u2013412. doi: 10.1016/j.euroneuro.2012.05.005.", "ArticleIdList": ["10.1016/j.euroneuro.2012.05.005", "22682406"]}, {"Citation": "Ludka FK, Constantino LC, Dal-Cim T, Binder LB, Zomkowski A, Rodrigues ALS, et al. Involvement of PI3K/Akt/GSK-3\u03b2 and mTOR in the antidepressant-like effect of atorvastatin in mice. J Psychiatr Res. 2016;82:50\u201357. doi: 10.1016/j.jpsychires.2016.07.004.", "ArticleIdList": ["10.1016/j.jpsychires.2016.07.004", "27468164"]}, {"Citation": "Ludka FK, Cunha MP, Dal-Cim T, Binder LB, Constantino LC, Massari CM, et al. Atorvastatin protects from A\u03b2 1\u201340-induced cell damage and depressive-like behavior via ProBDNF cleavage. Mol Neurobiol. 2017;54(8):6163\u20136173. doi: 10.1007/s12035-016-0134-6.", "ArticleIdList": ["10.1007/s12035-016-0134-6", "27709490"]}, {"Citation": "Lui VW, Hedberg ML, Li H, Vangara BS, Pendleton K, Zeng Y, et al. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013;3(7):761\u2013769. doi: 10.1158/2159-8290.CD-13-0103.", "ArticleIdList": ["10.1158/2159-8290.CD-13-0103", "PMC3710532", "23619167"]}, {"Citation": "Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 2012;441(1):1\u201321. doi: 10.1042/BJ20110892.", "ArticleIdList": ["10.1042/BJ20110892", "22168436"]}, {"Citation": "Mangravite LM, Engelhardt BE, Medina MW, Smith JD, Brown CD, Chasman DI, et al. A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. Nature. 2013;502(7471):377\u2013380. doi: 10.1038/nature12508.", "ArticleIdList": ["10.1038/nature12508", "PMC3933266", "23995691"]}, {"Citation": "Markowitsch SD, Schupp P, Lauckner J, Vakhrusheva O, Slade KS, Mager R, et al. Artesunate inhibits growth of sunitinib-resistant renal cell carcinoma cells through cell cycle arrest and induction of ferroptosis. Cancers. 2020;12(11):3150. doi: 10.3390/cancers12113150.", "ArticleIdList": ["10.3390/cancers12113150", "PMC7692972", "33121039"]}, {"Citation": "Martinet W, De Loof H, De Meyer GR. mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques. Atherosclerosis. 2014;233(2):601\u2013607. doi: 10.1016/j.atherosclerosis.2014.01.040.", "ArticleIdList": ["10.1016/j.atherosclerosis.2014.01.040", "24534455"]}, {"Citation": "Mayer IA, Arteaga CL. The PI3K/AKT pathway as a target for cancer treatment. Annu Rev Med. 2016;67:11\u201328. doi: 10.1146/annurev-med-062913-051343.", "ArticleIdList": ["10.1146/annurev-med-062913-051343", "26473415"]}, {"Citation": "McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest. 2008;133(2):507\u2013516. doi: 10.1378/chest.07-0898.", "ArticleIdList": ["10.1378/chest.07-0898", "18252917"]}, {"Citation": "McTaggart S. Isoprenylated proteins. Cell Mol Life Sci CMLS. 2006;63(3):255\u2013267. doi: 10.1007/s00018-005-5298-6.", "ArticleIdList": ["10.1007/s00018-005-5298-6", "16378247"]}, {"Citation": "Miyake H, Harada K-I, Kusuda Y, Fujisawa M. Efficacy and safety of temsirolimus in Japanese patients with metastatic renal cell carcinoma on hemodialysis. Int J Clin Oncol. 2013;18(6):1054\u20139. doi: 10.1007/s10147-012-0492-7.", "ArticleIdList": ["10.1007/s10147-012-0492-7", "23114786"]}, {"Citation": "Molinolo AA, Hewitt SM, Amornphimoltham P, Keelawat S, Rangdaeng S, Garc\u00eda AM, et al. Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res. 2007;13(17):4964\u20134973. doi: 10.1158/1078-0432.CCR-07-1041.", "ArticleIdList": ["10.1158/1078-0432.CCR-07-1041", "17785546"]}, {"Citation": "Morgan TM, Koreckij TD, Corey E. Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway. Curr Cancer Drug Targets. 2009;9(2):237\u2013249. doi: 10.2174/156800909787580999.", "ArticleIdList": ["10.2174/156800909787580999", "PMC2921605", "19275762"]}, {"Citation": "Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. The Lancet. 2016;387(10023):1094\u20131108. doi: 10.1016/S0140-6736(15)00130-0.", "ArticleIdList": ["10.1016/S0140-6736(15)00130-0", "26354523"]}, {"Citation": "Mullen PJ, Zahno A, Lindinger P, Maseneni S, Felser A, Kr\u00e4henb\u00fchl S, et al. Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt. Biochim Biophys Acta (BBA) 2011;1813(12):2079\u20132087. doi: 10.1016/j.bbamcr.2011.07.019.", "ArticleIdList": ["10.1016/j.bbamcr.2011.07.019", "21839782"]}, {"Citation": "Murata M. Inflammation and cancer. Environ Health Prev Med. 2018;23(1):1\u20138. doi: 10.1186/s12199-018-0740-1.", "ArticleIdList": ["10.1186/s12199-018-0740-1", "PMC6195709", "30340457"]}, {"Citation": "Nakao T, Shiota M, Tatemoto Y, Izumi Y, Iwao H. Pravastatin induces rat aortic endothelial cell proliferation and migration via activation of PI3K/Akt/mTOR/p70 S6 kinase signaling. J Pharmacol Sci. 2007;105(4):334\u2013341. doi: 10.1254/jphs.FP0070682.", "ArticleIdList": ["10.1254/jphs.FP0070682", "18057776"]}, {"Citation": "Nitzschke SL, Aden JK, Serio-Melvin ML, Shingleton SK, Chung KK, Waters J, et al. Wound healing trajectories in burn patients and their impact on mortality. J Burn Care Res. 2014;35(6):474\u2013479. doi: 10.1097/BCR.0000000000000039.", "ArticleIdList": ["10.1097/BCR.0000000000000039", "25144807"]}, {"Citation": "Ocon CA, Dos Santos SA, Caires JR, de Oliveira MFD, Serra AJ, Leal-Junior EC, et al. Effects and parameters of the photobiomodulation in experimental models of third-degree burn: systematic review. Lasers Med Sci. 2019;34(3):637\u2013648. doi: 10.1007/s10103-018-2633-3.", "ArticleIdList": ["10.1007/s10103-018-2633-3", "30229346"]}, {"Citation": "Okubo K, Isono M, Miyai K, Asano T, Sato A. Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells. Cancer Sci. 2020;111(1):112\u2013126. doi: 10.1111/cas.14225.", "ArticleIdList": ["10.1111/cas.14225", "PMC6942444", "31675763"]}, {"Citation": "Oliver G, Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 2002;16(7):773\u2013783. doi: 10.1101/gad.975002.", "ArticleIdList": ["10.1101/gad.975002", "11937485"]}, {"Citation": "Ong C, Khoo Y, Mukhopadhyay A, Do D, Lim I, Aalami O, et al. mTOR as a potential therapeutic target for treatment of keloids and excessive scars. Exp Dermatol. 2007;16(5):394\u2013404. doi: 10.1111/j.1600-0625.2007.00550.x.", "ArticleIdList": ["10.1111/j.1600-0625.2007.00550.x", "17437482"]}, {"Citation": "Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS. Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014. JAMA Oncol. 2018;4(9):1254\u20131262. doi: 10.1001/jamaoncol.2018.1789.", "ArticleIdList": ["10.1001/jamaoncol.2018.1789", "PMC6143018", "29931168"]}, {"Citation": "Ouahoud S, Jacobs RJ, Peppelenbosch MP, F\u00fchler G, Heijmans J, Diks S, et al. Kinome-wide analysis of the effect of statins in colorectal cancer. Br J Cancer. 2021 doi: 10.1038/s41416-021-01426-6.", "ArticleIdList": ["10.1038/s41416-021-01426-6", "PMC8184819", "33742146"]}, {"Citation": "Ouahoud S, Jacobs RJ, Peppelenbosch MP, F\u00fchler G, Heijmans J, Diks S, et al. Kinome-wide analysis of the effect of statins in colorectal cancer. Br J Cancer. 2021;124(12):1978\u20131987. doi: 10.1038/s41416-021-01318-9.", "ArticleIdList": ["10.1038/s41416-021-01318-9", "PMC8184819", "33742146"]}, {"Citation": "Pal SK, Ali SM, Yakirevich E, Geynisman DM, Karam JA, Elvin JA, et al. Characterization of clinical cases of advanced papillary renal cell carcinoma via comprehensive genomic profiling. Eur Urol. 2018;73(1):71\u201378. doi: 10.1016/j.eururo.2017.05.033.", "ArticleIdList": ["10.1016/j.eururo.2017.05.033", "28592388"]}, {"Citation": "Pal R, Banerjee M, Yadav U, Bhattacharjee S. Statin use and clinical outcomes in patients with COVID-19: an updated systematic review and meta-analysis. Postgrad Med J. 2021 doi: 10.1136/postgradmedj-2020-139172.", "ArticleIdList": ["10.1136/postgradmedj-2020-139172", "33541927"]}, {"Citation": "Park HJ, Shin JY, Kim HN, Oh SH, Lee PH. Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model. Neurobiol Aging. 2014;35(8):1920\u20131928. doi: 10.1016/j.neurobiolaging.2014.01.028.", "ArticleIdList": ["10.1016/j.neurobiolaging.2014.01.028", "24629674"]}, {"Citation": "Parizadeh SM, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour-Mobarhan M, Tavallaie S, Rahsepar AA, Amini M, Sahebkar A, Mohammadi M, Ferns GA (2011) Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial. Lipids 46(4):333\u2013340. 10.1007/s11745-010-3517-x", "ArticleIdList": ["21207250"]}, {"Citation": "Pazhooh RD, Farnood PR, Asemi Z, Mirsafaei L, Yousefi B, Mirzaei H. mTOR pathway and DNA damage response: a therapeutic strategy in cancer therapy. DNA Repair. 2021 doi: 10.1016/j.dnarep.2021.103142.", "ArticleIdList": ["10.1016/j.dnarep.2021.103142", "34102579"]}, {"Citation": "Pickering RJ. Oxidative stress and inflammation in cardiovascular diseases. Multidisciplinary Digital Publishing Institute; 2021.", "ArticleIdList": ["PMC7912407", "33503818"]}, {"Citation": "Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Statins: pros and cons. Med Cl\u00edn (English Edition) 2018;150(10):398\u2013402. doi: 10.1016/j.medcle.2018.03.001.", "ArticleIdList": ["10.1016/j.medcle.2018.03.001", "PMC6019636", "29292104"]}, {"Citation": "Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3(1):1\u201321. doi: 10.1038/nrdp.2017.13.", "ArticleIdList": ["10.1038/nrdp.2017.13", "28332488"]}, {"Citation": "Pratt AJ, Getzoff ED, Perry JJP. Amyotrophic lateral sclerosis: update and new developments. Degener Neurol Neuromuscul Dis. 2012;2:1.", "ArticleIdList": ["PMC3457793", "23019386"]}, {"Citation": "Qu W-H, Yu S-X, Sui H-J, Jin Y-X, Jin X-N, Jin Y (2013) Atorvastatin promotes neurite growth by activating PI3K/Akt/mTOR signal transduction. Cin J Pharmacol Toxicol 27(2):150\u2013155"}, {"Citation": "Ramhormozi P, Ansari JM, Simorgh S, Asgari HR, Najafi M, Barati M, et al. Simvastatin accelerates the healing process of burn wound in Wistar rats through Akt/mTOR signaling pathway. Ann Anat-Anatomischer Anzeiger. 2021;236:151652. doi: 10.1016/j.aanat.2020.151652.", "ArticleIdList": ["10.1016/j.aanat.2020.151652", "33278579"]}, {"Citation": "Reiner \u017d. Resistance and intolerance to statins. Nutr Metab Cardiovasc Dis. 2014;24(10):1057\u20131066. doi: 10.1016/j.numecd.2014.05.009.", "ArticleIdList": ["10.1016/j.numecd.2014.05.009", "24996502"]}, {"Citation": "Rezvanian M, Ng S-F, Alavi T, Ahmad W. In-vivo evaluation of Alginate-Pectin hydrogel film loaded with Simvastatin for diabetic wound healing in Streptozotocin-induced diabetic rats. Int J Biol Macromol. 2021;171:308\u2013319. doi: 10.1016/j.ijbiomac.2020.12.221.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.12.221", "33421467"]}, {"Citation": "Rodrigues-Diez RR, Tejera-Mu\u00f1oz A, Marquez-Exposito L, Rayego-Mateos S, Santos Sanchez L, Marchant V, et al. Statins: could an old friend help in the fight against COVID-19? Br J Pharmacol. 2020;177(21):4873\u20134886. doi: 10.1111/bph.15166.", "ArticleIdList": ["10.1111/bph.15166", "PMC7323198", "32562276"]}, {"Citation": "Rose BS, Jeong J-H, Nath SK, Lu SM, Mell LK. Population-based study of competing mortality in head and neck cancer. J Clin Oncol. 2011;29(26):3503\u20133509. doi: 10.1200/JCO.2011.35.7301.", "ArticleIdList": ["10.1200/JCO.2011.35.7301", "21844503"]}, {"Citation": "Rosenfeldt MT, O\u2019Prey J, Morton JP, Nixon C, MacKay G, Mrowinska A, et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature. 2013;504(7479):296\u2013300. doi: 10.1038/nature12865.", "ArticleIdList": ["10.1038/nature12865", "24305049"]}, {"Citation": "Roudsari NM, Lashgari N-A, Zandi N, Pazoki B, Momtaz S, Sahebkar A, et al. PPAR\u03b3: a turning point for irritable bowel syndrome treatment. Life Sci. 2020;257:118103. doi: 10.1016/j.lfs.2020.118103.", "ArticleIdList": ["10.1016/j.lfs.2020.118103", "32681913"]}, {"Citation": "Roudsari NM, Lashgari N-A, Momtaz S, Abaft S, Jamali F, Safaiepour P, et al. Inhibitors of the PI3K/Akt/mTOR pathway in prostate cancer chemoprevention and intervention. Pharmaceutics. 2021;13(8):1195. doi: 10.3390/pharmaceutics13081195.", "ArticleIdList": ["10.3390/pharmaceutics13081195", "PMC8400324", "34452154"]}, {"Citation": "Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. Am J Psychiatry. 2006;163(11):1905\u20131917. doi: 10.1176/ajp.2006.163.11.1905.", "ArticleIdList": ["10.1176/ajp.2006.163.11.1905", "17074942"]}, {"Citation": "Saaristo A, Tammela T, F\u0101rkkil\u0101 A, K\u00e4rkk\u00e4inen M, Suominen E, Yla-Herttuala S, et al. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am J Pathol. 2006;169(3):1080\u20131087. doi: 10.2353/ajpath.2006.051251.", "ArticleIdList": ["10.2353/ajpath.2006.051251", "PMC1698814", "16936280"]}, {"Citation": "Sahebkar A, Watts GF. New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: What can the clinician expect? Cardiovasc Drugs Ther. 2013;27(6):559\u2013567. doi: 10.1007/s10557-013-6479-4.", "ArticleIdList": ["10.1007/s10557-013-6479-4", "23913122"]}, {"Citation": "Sahebkar A, Watts GF. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Clin Ther. 2013;35(8):1082\u20131098. doi: 10.1016/j.clinthera.2013.06.019.", "ArticleIdList": ["10.1016/j.clinthera.2013.06.019", "23932550"]}, {"Citation": "Sahebkar A, Serban C, Mikhailidis DP, Undas A, Lip GY, Muntner P, Bittner V, Ray KK, Watts GF, Hovingh GK, Rysz J, Kastelein JJ, Banach M, Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group (2015). Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials. Thromb Haemost 114(3):546\u2013557. 10.1160/TH14-11-0937", "ArticleIdList": ["26017749"]}, {"Citation": "Sakamoto K, Wada I, Kimura J. Inhibition of Rab1 GTPase and endoplasmic reticulum-to-Golgi trafficking underlies statin's toxicity in rat skeletal myofibers. J Pharmacol Exp Ther. 2011;338(1):62\u201369. doi: 10.1124/jpet.111.179762.", "ArticleIdList": ["10.1124/jpet.111.179762", "21467191"]}, {"Citation": "Sartor O, de Bono JS. Metastatic prostate cancer. N Engl J Med. 2018;378(7):645\u2013657. doi: 10.1056/NEJMra1701695.", "ArticleIdList": ["10.1056/NEJMra1701695", "29412780"]}, {"Citation": "Saso S, Chatterjee J, Georgiou E, Ditri AM, Smith JR, Ghaem-Maghami S. Endometrial cancer. BMJ. 2011 doi: 10.1136/bmj.d3954.", "ArticleIdList": ["10.1136/bmj.d3954", "21734165"]}, {"Citation": "Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960\u2013976. doi: 10.1016/j.cell.2017.02.004.", "ArticleIdList": ["10.1016/j.cell.2017.02.004", "PMC5394987", "28283069"]}, {"Citation": "Schiaffino S, Mammucari C. Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skeletal Muscle. 2011;1(1):1\u201314. doi: 10.1186/2044-5040-1-4.", "ArticleIdList": ["10.1186/2044-5040-1-4", "PMC3143906", "21798082"]}, {"Citation": "Schointuch MN, Gilliam TP, Stine JE, Han X, Zhou C, Gehrig PA, et al. Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer. Gynecol Oncol. 2014;134(2):346\u2013355. doi: 10.1016/j.ygyno.2014.05.015.", "ArticleIdList": ["10.1016/j.ygyno.2014.05.015", "PMC4125536", "24880141"]}, {"Citation": "Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 2007;7(4):295\u2013308. doi: 10.1038/nrc2109.", "ArticleIdList": ["10.1038/nrc2109", "17384584"]}, {"Citation": "Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst. 2005;97(5):347\u2013357. doi: 10.1093/jnci/dji050.", "ArticleIdList": ["10.1093/jnci/dji050", "15741571"]}, {"Citation": "Serban C, Sahebkar A, Ursoniu S, Mikhailidis DP, Rizzo M, Lip GY, Kees Hovingh G, Kastelein JJ, Kalinowski L, Rysz J, Banach M (2015) A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Sci Rep 5:9902. 10.1038/srep09902", "ArticleIdList": ["PMC4429557", "25970700"]}, {"Citation": "Shakour N, Ruscica M, Hadizadeh F, Cirtori C, Banach M, Jamialahmadi T, et al. Statins and C-reactive protein: in silico evidence on direct interaction. Arch Med Sci. 2020;16(6):1432\u20131439. doi: 10.5114/aoms.2020.100304.", "ArticleIdList": ["10.5114/aoms.2020.100304", "PMC7667423", "33224343"]}, {"Citation": "Sheng B, Song Y, Zhang J, Li R, Wang Z, Zhu X. Atorvastatin suppresses the progression of cervical cancer via regulation of autophagy. Am J Trans Res. 2020;12(9):5252.", "ArticleIdList": ["PMC7540084", "33042417"]}, {"Citation": "Simic I, Reiner Z. Adverse effects of statins-myths and reality. Curr Pharm Des. 2015;21(9):1220\u20131226. doi: 10.2174/1381612820666141013134447.", "ArticleIdList": ["10.2174/1381612820666141013134447", "25312733"]}, {"Citation": "Sohrevardi SM, Nasab FS, Mirjalili MR, Bagherniya M, Tafti AD, Jarrahzadeh MH, et al. Effect of atorvastatin on delirium status of patients in the intensive care unit: a randomized controlled trial. Arch Med Sci. 2021;17(5):1423. doi: 10.5114/aoms.2019.89330.", "ArticleIdList": ["10.5114/aoms.2019.89330", "PMC8425261", "34522273"]}, {"Citation": "Squarize CH, Castilho RM, Bugge TH, Gutkind JS. Accelerated wound healing by mTOR activation in genetically defined mouse models. PLoS One. 2010;5(5):e10643. doi: 10.1371/journal.pone.0010643.", "ArticleIdList": ["10.1371/journal.pone.0010643", "PMC2869363", "20498714"]}, {"Citation": "Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo W-L, Davies M, et al. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Can Res. 2008;68(15):6084\u20136091. doi: 10.1158/0008-5472.CAN-07-6854.", "ArticleIdList": ["10.1158/0008-5472.CAN-07-6854", "PMC2680495", "18676830"]}, {"Citation": "Stine J, Schointuch M, Zhou C, Gilliam T, Han X, Gehrig P, et al. Simvastatin, an HMG-CoA reductase inhibitor, exhibits antimetastatic and antitumorigenic effects in endometrial cancer. Gynecol Oncol. 2014;133:112. doi: 10.1016/j.ygyno.2014.03.297.", "ArticleIdList": ["10.1016/j.ygyno.2014.03.297", "PMC4125536", "24880141"]}, {"Citation": "Stylianou N, Buchan I, Dunn KW. A review of the international Burn Injury Database (iBID) for England and Wales: descriptive analysis of burn injuries 2003\u20132011. BMJ Open. 2015 doi: 10.1136/bmjopen-2014-006184.", "ArticleIdList": ["10.1136/bmjopen-2014-006184", "PMC4346673", "25724981"]}, {"Citation": "Tajiri K, Shimojo N, Sakai S, Machino-Ohtsuka T, Imanaka-Yoshida K, Hiroe M, et al. Pitavastatin regulates mTOR Complex 1 signaling through inhibition of Rheb in T cells. Circulation. 2014;130(suppl_2):A13566-A. doi: 10.1161/circ.130.suppl_2.13566.", "ArticleIdList": ["10.1161/circ.130.suppl_2.13566"]}, {"Citation": "Tan C-C, Yu J-T, Tan M-S, Jiang T, Zhu X-C, Tan L. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy. Neurobiol Aging. 2014;35(5):941\u2013957. doi: 10.1016/j.neurobiolaging.2013.11.019.", "ArticleIdList": ["10.1016/j.neurobiolaging.2013.11.019", "24360503"]}, {"Citation": "Taniguti E, Ferreira Y, Stupp I, Fraga-Junior E, Doneda D, Lopes L, et al. Atorvastatin prevents lipopolysaccharide-induced depressive-like behaviour in mice. Brain Res Bull. 2019;146:279\u2013286. doi: 10.1016/j.brainresbull.2019.01.018.", "ArticleIdList": ["10.1016/j.brainresbull.2019.01.018", "30690060"]}, {"Citation": "Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18(1):11\u201322. doi: 10.1016/j.ccr.2010.05.026.", "ArticleIdList": ["10.1016/j.ccr.2010.05.026", "PMC3198787", "20579941"]}, {"Citation": "Thompson-Coon J, Hoyle M, Green C, Liu Z, Welch K, Moxham T, et al. Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation. Health Technol Assess. 2010 doi: 10.3310/hta14020.", "ArticleIdList": ["10.3310/hta14020", "20028613"]}, {"Citation": "Tiedemann K, Le Nihouannen D, Fong JE, Hussein O, Barralet JE, Komarova SV. Regulation of osteoclast growth and fusion by mTOR/raptor and mTOR/rictor/Akt. Front Cell Dev Biol. 2017;5:54. doi: 10.3389/fcell.2017.00054.", "ArticleIdList": ["10.3389/fcell.2017.00054", "PMC5435769", "28573133"]}, {"Citation": "Tomioka H, Nakagami H, Tenma A, Saito Y, Kaga T, Kanamori T, et al. Novel anti-microbial peptide SR-0379 accelerates wound healing via the PI3 kinase/Akt/mTOR pathway. PLoS One. 2014;9(3):e92597. doi: 10.1371/journal.pone.0092597.", "ArticleIdList": ["10.1371/journal.pone.0092597", "PMC3968008", "24675668"]}, {"Citation": "Torrealba N, Vera R, Fraile B, Mart\u00ednez-Onsurbe P, Paniagua R, Royuela M. TGF-\u03b2/PI3K/AKT/mTOR/NF-kB pathway. Clinicopathological features in prostate cancer. Aging Male. 2019 doi: 10.1080/13685538.2019.1597840.", "ArticleIdList": ["10.1080/13685538.2019.1597840", "30973040"]}, {"Citation": "Tsubaki M, Fujiwara D, Takeda T, Kino T, Tomonari Y, Itoh T, et al. The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin-induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathways. Clin Exp Pharmacol Physiol. 2017;44(2):222\u2013234. doi: 10.1111/1440-1681.12690.", "ArticleIdList": ["10.1111/1440-1681.12690", "27805296"]}, {"Citation": "Tuckow AP, Jefferson SJ, Kimball SR, Jefferson LS. Simvastatin represses protein synthesis in the muscle-derived C2C12 cell line with a concomitant reduction in eukaryotic initiation factor 2B expression. Am J Physiol-Endocrinol Metab. 2011;300(3):E564\u2013E570. doi: 10.1152/ajpendo.00383.2010.", "ArticleIdList": ["10.1152/ajpendo.00383.2010", "PMC3064004", "21224482"]}, {"Citation": "Vahedian-Azimi A, Mohammadi SM, Beni FH, Banach M, Guest PC, Jamialahmadi T, et al. Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis. Arch Med Sci. 2021;17(3):579\u2013595. doi: 10.5114/aoms/132950.", "ArticleIdList": ["10.5114/aoms/132950", "PMC8130467", "34025827"]}, {"Citation": "Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA. 2010;60(3):166\u201393.", "ArticleIdList": ["PMC2888474", "20445000"]}, {"Citation": "Wang T, Seah S, Loh X, Chan C-W, Hartman M, Goh B-C, et al. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway. Oncotarget. 2016;7(3):2532. doi: 10.18632/oncotarget.6304.", "ArticleIdList": ["10.18632/oncotarget.6304", "PMC4823053", "26565813"]}, {"Citation": "Ward NC, Watts GF, Eckel RH. Statin toxicity: mechanistic insights and clinical implications. Circ Res. 2019;124(2):328\u2013350. doi: 10.1161/CIRCRESAHA.118.312782.", "ArticleIdList": ["10.1161/CIRCRESAHA.118.312782", "31170055"]}, {"Citation": "Weichhart T. mTOR as regulator of lifespan, aging, and cellular senescence: a mini-review. Gerontology. 2018;64(2):127\u2013134. doi: 10.1159/000484629.", "ArticleIdList": ["10.1159/000484629", "PMC6089343", "29190625"]}, {"Citation": "White E. The role for autophagy in cancer. J Clin Investig. 2015;125(1):42\u201346. doi: 10.1172/JCI73941.", "ArticleIdList": ["10.1172/JCI73941", "PMC4382247", "25654549"]}, {"Citation": "White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res. 2009;15(17):5308\u20135316. doi: 10.1158/1078-0432.CCR-07-5023.", "ArticleIdList": ["10.1158/1078-0432.CCR-07-5023", "PMC2737083", "19706824"]}, {"Citation": "Witte MH, Bernas MJ, Martin CP, Witte CL. Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc Res Tech. 2001;55(2):122\u2013145. doi: 10.1002/jemt.1163.", "ArticleIdList": ["10.1002/jemt.1163", "11596157"]}, {"Citation": "Woodard J, Sassano A, Hay N, Platanias LC. Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma. Clin Cancer Res. 2008;14(14):4640\u20134649. doi: 10.1158/1078-0432.CCR-07-5232.", "ArticleIdList": ["10.1158/1078-0432.CCR-07-5232", "18628479"]}, {"Citation": "Xia Z, Tan MM, Wong WW, Dimitroulakos J, Minden MD, Penn LZ. Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. Leukemia. 2001;15(9):1398\u20131407. doi: 10.1038/sj.leu.2402196.", "ArticleIdList": ["10.1038/sj.leu.2402196", "11516100"]}, {"Citation": "Xing W, Guo W, Zou C-H, Fu T-T, Li X-Y, Zhu M, et al. Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway. J Dermatol Sci. 2015;79(2):101\u2013109. doi: 10.1016/j.jdermsci.2015.03.016.", "ArticleIdList": ["10.1016/j.jdermsci.2015.03.016", "26049685"]}, {"Citation": "Yang H, Rudge DG, Koos JD, Vaidialingam B, Yang HJ, Pavletich NP. mTOR kinase structure, mechanism and regulation. Nature. 2013;497(7448):217\u2013223. doi: 10.1038/nature12122.", "ArticleIdList": ["10.1038/nature12122", "PMC4512754", "23636326"]}, {"Citation": "Yang H, Chen X, Liu M, Xu Y. The structure of mTOR complexes at a glance. Precis Cancer Med. 2018;1(9):7\u20137. doi: 10.21037/pcm.2018.07.02.", "ArticleIdList": ["10.21037/pcm.2018.07.02"]}, {"Citation": "Yu X-B, Zhang H-N, Dai Y, Zhou Z-Y, Xu R-A, Hu L-F, et al. Simvastatin prevents and ameliorates depressive behaviors via neuroinflammatory regulation in mice. J Affect Disord. 2019;245:939\u2013949. doi: 10.1016/j.jad.2018.11.086.", "ArticleIdList": ["10.1016/j.jad.2018.11.086", "30699879"]}, {"Citation": "Zandi N, Pazoki B, Roudsari NM, Lashgari N-A, Jamshidi V, Momtaz S, et al. Prospects of saffron and its derivatives in Alzheimer\u2019s disease. Arch Iran Med. 2021;24(3):233. doi: 10.34172/aim.2021.35.", "ArticleIdList": ["10.34172/aim.2021.35", "33878882"]}, {"Citation": "Zhang Q, Kelly AP, Wang L, French SW, Tang X, Duong HS, et al. Green tea extract and (\u2212)-epigallocatechin-3-gallate inhibit mast cell-stimulated type I collagen expression in keloid fibroblasts via blocking PI-3K/Akt signaling pathways. J Investig Dermatol. 2006;126(12):2607\u20132613. doi: 10.1038/sj.jid.5700472.", "ArticleIdList": ["10.1038/sj.jid.5700472", "16841034"]}, {"Citation": "Zhao F, Liu W, Yu Y, Liu X, Yin H, Liu L, et al. Effect of small molecular weight soybean protein-derived peptide supplementation on attenuating burn injury-induced inflammation and accelerating wound healing in a rat model. RSC Adv. 2019;9(3):1247\u20131259. doi: 10.1039/C8RA09036J.", "ArticleIdList": ["10.1039/C8RA09036J", "PMC9059567", "35518054"]}, {"Citation": "Zhu Z, Zhang P, Li N, Kiang KMY, Cheng SY, Wong VK-W, et al. Lovastatin enhances cytotoxicity of temozolomide via impairing autophagic flux in glioblastoma cells. BioMed Res Int. 2019 doi: 10.1155/2019/2710693.", "ArticleIdList": ["10.1155/2019/2710693", "PMC6778891", "31662972"]}, {"Citation": "Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015;67(3):519\u2013530. doi: 10.1016/j.eururo.2014.10.002.", "ArticleIdList": ["10.1016/j.eururo.2014.10.002", "25449206"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "3"}, {"Year": "2022", "Month": "7", "Day": "12"}, {"Year": "2022", "Month": "12", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "27", "Hour": "11", "Minute": "17"}, {"Year": "2022", "Month": "12", "Day": "27"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36574095", "PMC9792946", "10.1007/s10787-022-01077-w", "10.1007/s10787-022-01077-w"]}}], "PubmedBookArticle": []}